Defunct Company
Total Trials
5
As Lead Sponsor
0
As Collaborator
Total Enrollment
100
NCT00322491
Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
Phase: Phase 2
Role: Collaborator
Start: Mar 31, 2004
Completion: Jun 30, 2006
NCT00322842
Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
Start: Sep 30, 2004
Completion: Feb 28, 2007
NCT00396383
Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation
Start: Nov 30, 2004
Completion: May 31, 2007
NCT00476294
Long-Term Follow Up Study for AMD3100 Patients
Phase: N/A
Start: Oct 31, 2006
Completion: Jul 31, 2012